Riluzole (KAISER FOUNDATION HOSPITALS)
Welcome to the PulseAid listing for the Riluzole drug offered from KAISER FOUNDATION HOSPITALS. This Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | KAISER FOUNDATION HOSPITALS |
NON-PROPRIETARY NAME: | Riluzole |
SUBSTANCE NAME: | RILUZOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Benzothiazole [EPC],Benzothiazoles [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-05-14 |
END MARKETING DATE: | 0000-00-00 |
Riluzole HUMAN PRESCRIPTION DRUG Details:
Item Description | Riluzole from KAISER FOUNDATION HOSPITALS |
LABELER NAME: | KAISER FOUNDATION HOSPITALS |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 50(mg/1) |
START MARKETING DATE: | 2014-05-14 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0179-0150_a361dab4-4407-4297-83e9-45e1ab7d3df1 |
PRODUCT NDC: | 0179-0150 |
APPLICATION NUMBER: | ANDA091417 |
Other RILUZOLE Pharmaceutical Manufacturers / Labelers: